Is Shenzhen Salubris Pharmaceuticals Co Ltd Stock Halal?

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 4,087 full-time employees. The company went IPO on 2009-09-10. The firm's main products include cardiovascular drugs and medical devices, cephalosporin antibiotics and raw materials, orthopedic drugs and others. The firm's productpipeline covers key areas of interventional therapy such as cardiovascular and cerebrovascular diseases, peripheral blood vessels, structural heart diseases, electrophysiology and cardiac rhythm management. The firm's products are mainly used in the treatment of cardiovascular and cerebrovascular diseases, hypoglycemic, nephrology, orthopedics and anti-tumor. The firm distributes its products within domestic market and to overseas markets.